Literature DB >> 17874013

Comparison of different methods to measure experimental chronic infarction size in the rat model.

Marcos F Minicucci1, Paula S Azevedo, Daniella R Duarte, Beatriz B Matsubara, Luiz S Matsubara, Alvaro O Campana, Sergio A R Paiva, Leonardo A M Zornoff.   

Abstract

OBJECTIVE: To evaluate the differences between three methods for the measurement of experimental infarction in rats in comparison to the traditional method.
METHODS: Histological analysis of the infarction area (AREA), histological analysis of the internal cavity perimeter (PER) and echocardiogram analysis of the internal perimeter (ECHO) were compared to the traditional method (histological analysis of the epicardial and endocardial circumferences of the infarction region - CIR). Repeated ANOVA measurements were used in conjunction with the Dunn multiple comparison test, the Bland and Altman concordance method and the Spearman correlation test. Significance was established as p < 0.05.
RESULTS: The data of 122 animals were analyzed, 3 to 6 months after the infarction. Infarction size assessments revealed differences between CIR and the other three methods (p < 0.001): CIR = 42.4% (35.9-48.8), PER = 50.3% (39.1-57.0), AREA = 27.3% (20.2-34.3), ECHO = 46.1% (39.9-52.6). Therefore, measurement by area underestimated the infarct size by 15%, whereas the echocardiogram and histological internal perimeter measurements overestimated the infarct size by 4% and 5%, respectively. In relation to ECHO and PER, even though the difference between the methods was only 1.27%, the concordance interval ranged from 24.1% to -26.7%, suggesting a low level of concordance between the methods. In relation to associations, statistically significant correlations were found between: CIR and PER (r = 0.88 and p < 0.0001); CIR and AREA (r = 0.87 and p < 0.0001) and CIR and ECHO (r = 0.42 and p < 0.0001).
CONCLUSION: Despite the high level of correlation, there was a low level of concordance between the methods to define infarct size.

Entities:  

Mesh:

Year:  2007        PMID: 17874013     DOI: 10.1590/s0066-782x2007001400004

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  5 in total

1.  Myostatin and follistatin expression in skeletal muscles of rats with chronic heart failure.

Authors:  Aline Regina Ruiz Lima; Paula Felippe Martinez; Katashi Okoshi; Daniele Mendes Guizoni; Leonardo A Mamede Zornoff; Dijon Henrique Salomé Campos; Sílvio Assis Oliveira; Camila Bonomo; Maeli Dal Pai-Silva; Marina Politi Okoshi
Journal:  Int J Exp Pathol       Date:  2009-12-03       Impact factor: 1.925

2.  Early echocardiographic predictors of increased left ventricular end-diastolic pressure three months after myocardial infarction in rats.

Authors:  Paula S Azevedo; Bertha F Polegato; Marcos F Minicucci; Stephan M Pio; Igor A Silva; Priscila P Santos; Katashi Okoshi; Sergio A R Paiva; Leonardo A M Zornoff
Journal:  Med Sci Monit       Date:  2012-07

3.  MIQuant--semi-automation of infarct size assessment in models of cardiac ischemic injury.

Authors:  Diana S Nascimento; Mariana Valente; Tiago Esteves; Maria de Fátima de Pina; Joana G Guedes; Ana Freire; Pedro Quelhas; Perpétua Pinto-do-Ó
Journal:  PLoS One       Date:  2011-09-30       Impact factor: 3.240

4.  High plasma concentrations of asymmetric dimethylarginine inhibit ischemic cardioprotection in hypercholesterolemic rats.

Authors:  M B P Landim; P M M Dourado; A Casella-Filho; A C P Chagas; P L da-Luz
Journal:  Braz J Med Biol Res       Date:  2013-05-10       Impact factor: 2.590

5.  Gualou Xiebai decoction inhibits cardiac dysfunction and inflammation in cardiac fibrosis rats.

Authors:  Yong-fang Ding; Yun-ru Peng; Hong Shen; Luan Shu; Ying-jie Wei
Journal:  BMC Complement Altern Med       Date:  2016-02-04       Impact factor: 3.659

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.